Antinuclear antibody, lupus anticoagulant, and anticardiolipin antibody in women with idiopathic habitual abortion. A controlled, prospective study of forty‐four women
- 1 June 1987
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 30 (6) , 601-606
- https://doi.org/10.1002/art.1780300601
Abstract
In a controlled, prospective study of 44 consecutive women with idiopathic habitual abortion, only 5% had symptoms of rheumatic disease. Patients did not differ from control subjects in the frequency of positive results on tests for antinuclear antibody or anti-double-stranded DNA. Levels of C3 and C4 were higher in the habitual aborters. No patients had anti-Ro. The antiphospholipid antibody results were analyzed using 2 methods: the frequency of antiphospholipid antibodies was 9% by lupus anticoagulant using the Russell viper venom time (95% confidence interval 22–2.5) and 11% by anticardiolipin antibody assay (95% confidence interval 25–3.7), which was not significantly different from that in control subjects. However, the mean levels in the aborters (although within the normal range) were significantly higher than those in control subjects for anti-double-stranded DNA (P = 0.004), lupus anticoagulant (by Russell viper venom time; P = 0.05), and anticardiolipin antibody (P = 0.0007), when examined by multiple linear regression analysis corrected for age and concurrent pregnancy. Of the 3 patients with antiphospholipid antibodies and subsequent successful pregnancies, only 1 was treated with prednisone and aspirin. We conclude that, in the majority of women, subclinical lupus, anti-Ro, the lupus anticoagulant, and anticardiolipin antibodies are not associated with idiopathic habitual abortion.This publication has 31 references indexed in Scilit:
- Antiphospholipid Antibodies and PregnancyNew England Journal of Medicine, 1985
- Lupus Anticoagulant, Thrombosis, and Fetal LossNew England Journal of Medicine, 1985
- Obstetric Complications Associated with the Lupus AnticoagulantNew England Journal of Medicine, 1985
- LUPUS ANTICOAGULANT: A PLACE FOR PRE-PREGNANCY TREATMENT?The Lancet, 1985
- Antibody to Cardiolipin as a Predictor of Fetal Distress or Death in Pregnant Patients with Systemic Lupus ErythematosusNew England Journal of Medicine, 1985
- Antinuclear, anticytoplasmic, and anti-Sjogren's Syndrome antigen A (SS-A/Ro) antibodies in female blood donorsClinical Immunology and Immunopathology, 1985
- Post-Transplantation Reticulum-Cell Sarcoma Reclassified as B-Cell LymphomaNew England Journal of Medicine, 1985
- Fetal loss in systemic lupus: association with anticardiolipin antibodiesJournal of Obstetrics and Gynaecology, 1985
- The Lupus Inhibitor in Thromboembolic Disease and Intrauterine Death in the Absence of Systemic LupusActa Medica Scandinavica, 1984
- POSSIBLE RELATIONSHIP BETWEEN LUPUS INHIBITOR AND RECURRENT ABORTION IN YOUNG WOMENThe Lancet, 1980